In this interview, conducted by Keystone Marketing’s Scott Broady, Denise Deakin, Co-Founder & President of Scimega Oncology answers questions about her company’s customer-centric approach to the conduct of oncology clinical trials. Ms. Deakin talks about how the innovative Reverse Feasibility Program has been instrumental in creating value for all stakeholders and why it’s also been a great marketing tool.
Interested in Learning More About the Canadian Opportunity?